FLT3 and acute myeloid leukemia: In addition to KMT2A rearrangements, KMT2A‐r‐AML may carry cooperating genetic alterations in genes such as FLT3, NPM1, and IDH1/2, further contributing to the disease's pathogenesis and clinical behavior [33, 34].